🇺🇸 FDA
Pipeline program

Imdusiran (AB-729)

HP-00106061

Phase 2 small_molecule active

Quick answer

Imdusiran (AB-729) for Chronic Hepatitis B is a Phase 2 program (small_molecule) at Arbutus Biopharma Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Arbutus Biopharma Corp
Indication
Chronic Hepatitis B
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials